BRNS   $1.12  -8.20% Market Closed

Barinthus Biotherapeutics PLC
Total Cash 117.77M
totalCashPerShare 2.988
EBITDA -65.60M
Total Debt 12.57M
quickRatio 7.918
currentRatio 8.46
Total Revenue 0.00
debtToEquity 8.017
Revenue/Share 0.0
ROA -0.19695999
ROE -0.34127998
grossProfits
freeCashflow -33.24M
operatingCashflow -54.62M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -48.59M
forwardPE -0.88395065
floatShares 27.36M
sharesOutstanding 39.41M
sharesShort 3.98K
sharesShortPriorMonth 6.00K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.48%
Short Ratio help_outline 0.11%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 3.997
Price To Book help_outline 0.36
earningsQuarterlyGrowth
netIncomeToCommon -63.78M
trailingEps -1.64%
forwardEps -1.62%
enterpriseToEbitda 0.74
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.44 3Q 2024
institutionsCount 21
lastUpdated Nov. 2, 2024, 6:41 a.m.